CN Patent

CN108601916B — 直列式鼻部递送装置

Assigned to Inbell Pharmaceutical Co · Expires 2021-07-09 · 5y expired

What this patent protects

一种用于复合物的递送装置包括：壳体、保持复合物的药瓶和推进剂源，其中壳体提供入口和用于药瓶的出口，其中入口与推进剂源流体连通，并且背向直列式鼻部递送装置复合物指向，并且出口允许复合物递送。

USPTO Abstract

一种用于复合物的递送装置包括：壳体、保持复合物的药瓶和推进剂源，其中壳体提供入口和用于药瓶的出口，其中入口与推进剂源流体连通，并且背向直列式鼻部递送装置复合物指向，并且出口允许复合物递送。

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: CN108601916B
Jurisdiction: CN
Classification: —
Expires: 2021-07-09
Drug substance claim: No
Drug product claim: No
Assignee: Inbell Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.